Proposal summaries
B3298 - Dynamic Changes in DNA Methylation as a Candidate Causal Pathway Between Adolescent Cannabis Exposure and Psychosis - 18/04/2019
The link between cannabis use and psychosis has been robustly documented. However, it is not known whether cannabis escalation in youth at risk for psychosis has a causal putative influence on reduced cognitive and psychiatric functioning, and whether changes in DNA methylation may mechanistically explain this association.
B3294 - 2 Sample MR Lung function and Cognition - 18/04/2019
Observational studies have reported associations between low lung function and dementia risk but cannot test causality of this relationship. If causal, interventions to maintain lung function with ageing could reduce the burden of dementia. It is unclear how early in life the association between low lung function and cognitive impairment begins.
Observational studies have shown an association between asthma and multi-morbidity, especially psychological e.g. anxiety and depression. However this work has been carried out on small numbers of patients, and is purely cross-sectional. Using ALSPAC data we can do larger studies longitudinally gaining insight into how early these affects appear, how long they last and how severe. If we find a consistent association then we may be able to test for causality.
B3296 - Exploring the associations between autistic traits and multiple risk behaviours MRB using the ALSPAC cohort - 18/04/2019
Previous research has shown associations between autistic traits and a higher risk of violent offending (adjusted relative risk = 1.39, 95% CI = 1.23â1.58).
Multiple risk behaviours such as smoking, alcohol consumption and antisocial behaviour are prevalent during adolescence and have also been shown to co-occur during this period. A growing body of evidence suggests that these behaviours are strongly associated, some causally, with adverse health outcomes in later life, including chronic health conditions, morbidity and premature mortality. It is therefore important to establish antecedents of MRB in order to develop effective interventions
B3295 - Internalising problems in children An epigenome-wide association study - 18/04/2019
Rationale: Internalising problems (depression & anxiety) in children have been found to be predictive of negative outcomes later in life (Sallis et al., 2018) but the biological mechanisms underlying the development of these disorders are not well understood. There is some evidence that epigenetics might play a role, but results are mixed (Barker, Walton, & Cecil, 2018). In this study, we will examine internalizing traits in childhood and methylation, both cross-sectionally and at birth.
B3293 - Exploring Illicit Drug Use in ALSPAC at age 24 comparison with general population and predictors of use - 18/04/2019
Substance use in young adulthood is associated with considerable morbidity, a situation which is substantially increasing, and a greater burden in young males [1]. SubstanceIllicit substance use of drugs use is taken to be illegal substances such as cannabis, cocaine, and synthetic stimulants . Use of these illegal substances is associated with an increased risks of addiction, overdose and long-term health effects, and therefore presents a significant public health concern. The link between substance use and poor mental health, educational attainment and subsequent employment is well documented [3]. Harms may be increased if use is during adolescence, a period of development is characterised by extensive cognitive and emotional development, which can be inhibited by substance use, and have a negative impact of future life outcomes [1]. A recent study suggested that in terms of brain development, adolescence should be considered up to age 25 [2]. Focussing on adolescence is important, as this is when most people start engaging in substance use, and therefore this period of life is important for the timing of preventative interventions [4]. Of interest is the substance use that persists throughout adolescence and into adulthood, which could progress to dependent use and be damaging to health.
However, there is marked global variation in prevalence of use of these substances, which indicates that contextual and individual factors influence this behaviour. As Mmuch of this data comes from self-reported questionnaires, and aspects of data collection may also affect differences in prevalence of reported use. Substance use is taken to be illegal substances such as cannabis, cocaine, and synthetic stimulants. Use of these illegal substances is associated with an increased risk of addiction, overdose and long-term health effects, and therefore presents a significant public health concern. Of interest is the substance use that persists throughout adolescence and into adulthood, which could progress to dependent use and be damaging to health. This period of adolescence is characterised by extensive cognitive and emotional development, which can be inhibited by substance use, and have a negative impact of future life outcomes [1]. A recent study suggested that in terms of brain development, adolescence should be considered up to age 25 [2]. The link between substance use and poor mental health, educational attainment and subsequent employment is well documented [3]. However, it is less clear why geographical variations in substance use occur, and the factors that predict drug use during young adulthood. Focussing on young adulthood is important as this is when most people start engaging in substance use, and therefore this period of life is important for the timing of preventative interventions [4]. To fully characterise the problem of substance use in this age group, more work is needed to understand the extent of substance use and identify risk factors that predict drug use.
B3288 - Exploring the associations between adverse childhood experiences ACEs and multiple risk behaviours MRB in adolescence - 09/04/2019
Adverse childhood experiences, or âACEsâ is a term which tells us if a young person has experienced any of a list of childhood adversities. We know that the more different ACEs people had experienced, the higher their risk of a range of negative physical and mental health outcomes is. Very little work has been done to test the predictors and outcomes of a wide ranging continuous score of multiple risk behaviours (MRB), so we are interested to see how well childhood ACEs predicts adolescent MRB.
B3292 - How weight and body size affect young peoples experience of school and academic achievement a qualitative study - 15/04/2019
Children who are above a âhealthyâ weight (medically classified as a BMI of over 25kg/m2) tend to do less well at school than their âhealthyâ weight peers. Studies which followed children up over time found those who were overweight or obese tended to do less well, particularly for maths. This difference was mainly found in girls, and tended to emerge in the teenage years.
Various ideas have been suggested to explain this relationship, ranging from health-related absences, to the impact of size-related bullying, to the unconscious bias of teachers. However, quantitative evidence to support these explanations is inconsistent, making it hard to draw clear conclusions. Surprisingly, there have been very few qualitative studies that ask young people, or their teachers, their views on this issue.
We want to explore if, how and why being above a âhealthyâ weight affects peopleâs experiences of school and their educational performance. To do this, we want to interview young people (aged 11-16 years) and young adults (from the ALSPAC cohort, aged â28 years) who are/were above a âhealthy weightâ in adolescence.
We will recruit young people (11-16 years) from community-based weight management services in Bristol and the surrounding areas. This will allow us to explore the views of young people currently in school.
However, we also want to understand how body size and weight might affect education beyond secondary-school level and its potential longer-term impact on young people as they enter the work environment. For this reason, we would also like to invite ALSPAC participants who were above a âhealthyâ weight in adolescence (11-16 years) to take part in interviews. As ALSPAC participants are now in their late twenties, they will be able to reflect on their entire educational âcareerâ, as well as describing if and how it impacted their employment and experience of the workplace.
B3290 - Non-transmitted genetics and genetic nurturing in ALSPAC - 15/04/2019
In this project we will investigate the presence of 'genetic nurturing' in ALSPAC across a range of phenotypes including educational attainment, smoking and alcohol intake. We will estimate genetic nurture as the contribution that parental genotype makes to offspring phenotype through expression of the parents phenotype by creating non-transmitted polygenic scores for ALSPAC participants. There is evidence of genetic nurturing effects for educational attainment (Kong et al, 2018) and we intend to extend this work to further phenotypes to assess how genetic nurture may vary across health and social traits. We will also examine a number of phenotypes for which there should be no genetic nurtutring effects (blood pressure, CRP, lipids) as negative control experiments.
B3289 - LONGITOOLS - H2020 Exposome application - 15/04/2019
LONGITOOLS will develop a holistic exposomic approach to this important health, societal and environmental challenge â LONGITOOLS will operationalise a very large and detailed set of longitudinal data with repeated measures spanning form the pre-conceptional period until late adulthood. The conceptualisation of the exposome paradigm defines the health status at any time during the life-course as being a function of a cumulative effect of all exposures an individual has been exposed to. In comparison to traditional models linking environmental exposure to a health outcome, an exposome-wide model will use the multiple dimensions within the data to reduce the fragmented view of a problem. Future opportunities to address the epidemic of MC-NCD, very likely to be a causal consequence of obesity, will depend on the capacity to:
i) model and utilise the correlation structure linking the environmental exposures to the life-course risk of MC-NCD e.g. social disadvantage linked to obesogenic urban design linked to pollution(s) linked to unhealthy behaviour (see impact section);
ii) define the possible paths (and the resilience factors) through which an unfavourable environment may cause health deterioration and
iii) identify from a silo of possible internal exposome how the environmental exposures convert into possible biological cause affecting the health risk (and vice-versa)
LONGITOOLSâs overarching aim is to harness the temporal dimensions in the exposome influencing the bi-directional association observed between individual health and the environment based on longitudinal models with repeated measures and survey of the exposome. The data incorporated as well as the researchers, knowledge managers and innovative network will be harnessed to demonstrate the temporal causality from the pre-conceptional period up until old age, with a dedicated focus on the life-course aetiology of circulatory, cardiac and metabolic NCDs.
We will empower this innovative consortium to adapt and develop statistical approaches of data-mining in exposomics with longitudinal built-in. We will focus on the changes in the epigenomic, metabolomics, and transcriptomics responses to encompass the internal dynamics. We will incorporate latent trajectory methods in the analysis of specific effect modifiers including diet, physical activity and behaviours. A first key exploitable tool for LONGITOOLS will be the integration in an exposome econometric life-course model of circulatory, cardiac and metabolic NCDs developed in longitudinal birth cohort studies. A second tool LONGITOOLS for impact will exploit our knowledge and innovative network to maximise impact towards innovative research, new technology and environmental and health policies.
All data and tools of LONGITOOLS will be harmonized alongside on-going European initiatives [DynaHEALTH, LifeCycle, BBMRI, EUCAN-Connect and EUCanSHare], Joint Project Initiatives PREcisE (ICL), NutriPROGRAM (EMC) and DiGuMet (CUT), we anticipate interaction with other funded projects to integrate LONGITOOLS into the EU Human Exposome Project Where additional health trajectories can be studied.
B3287 - Relationship between timing of puberty depressive symptoms and depression from adolescence to adulthood - 15/04/2019
The transition into puberty is a critical developmental period associated with profound biological and psychosocial changes. During early adolescence there is a dramatic rise in depressive symptoms in girls compared with boys. By the mid-teens, girls are twice as likely to experience depression than boys, and this gender difference persists through adult life. Adolescence is, therefore, the key developmental period for the female rise in depression. The timing of the pubertal transition is of interest because early puberty in girls has been linked to a range of adverse outcomes in psychological, social, sexual and educational domains. Girls who mature earlier than their peers face a cascade of psychosocial challenges that may be inconsistent with their level of cognitive and emotional development. This may lead to feelings of isolation and increased vulnerability to depression. It is still unclear, however, whether adverse outcomes associated with early puberty translate into longer-term negative consequences for mental health in young women. Timing of puberty could also be important in determining risk for depressive symptoms/depression in boys, but findings are inconsistent and more research is needed. Few studies have examined mechanisms through which timing of puberty affects risk for depressive symptoms/depression. Psychosocial theories propose that individual and social factors explain more of the variance in adolescent depression than hormones alone.
B3286 - Predictors and outcomes of tinnitus in childhood through to adulthood - 14/10/2019
Tinnitus is the subjective perception of sound in the head or ears, typically whistling or buzzing sounds. Our earlier study of tinnitus using ALSPAC showed it was common in childhood with a prevalence of ~28% at age 11; clinically significant tinnitus was much less common however, at around 3%. In adulthood, the prevalence is around 1 in 10, and the most common risk factors are hearing loss and increasing age. It is not known whether tinnitus in childhood predicts adult tinnitus.
Having tinnitus is associated with increased levels of anxiety and depression but is unclear whether this is a consequence of tinnitus, or whether people with higher levels of anxiety and depression are more likely to report and seek help for their tinnitus. There is also an association of tinnitus with particular psychological traits such as neuroticism but the direction of causality is not known. Finally links have been described between tinnitus and suicide, but it is not known whether these relate to the co-occurring depression and hearing loss that often come with tinnitus.
We therefore aim to examine risk factors and outcomes for tinnitus in both childhood and adulthood in the ALSPAC cohort.
B3284 - Long-term otitis media with effusion and hearing loss and its impact on developmental outcomes - 15/04/2019
Otitis media with effusion (OME) is a common condition in childhood. Generally, the condition is asymptomatic and resolves within 3 months. However, in some cases the condition persists and results in conductive hearing loss. For children whose OME lasts 3 months or more, they may be provided with treatment through insertion of a ventilation tube (grommet) through their eardrum or they may be fitted with a hearing aid.
Despite OME being a temporary condition, it is estimated that 30-40% of children have recurrent OME over several years. By age 6 to 7 years, prevalence of OME drops to around 3-8%. The literature on OME & hearing loss, and its impact on child development has mainly focused on the early years, with little investigation of those with OME persisting beyond age 7. Hence, we aim to investigate the relationship between long-term OME and hearing loss (defined here as persisting beyond age 7) and developmental outcomes in late childhood in a prospective longitudinal cohort study.
B3285 - EXPANSE EXposome Powered tools for healthy living in urbAN SEttings - 13/06/2019
The environment we live in has a dominant impact on our health. It explains an estimated 70% of the chronic disease burden. As most of the aspects of our environment are modifiable, this provides a huge potential for disease prevention. Derived from the term exposure, the Exposome is the sum of all non-genetic drivers of health and diseases. Interacting with the genome, it defines individual health at different stages throughout the life course, inlcuding foetal life. The Exposome can be considered from two complementary angles: the External Exposome, comprising aspects of the built environment, the social environment, the physico-chemical environment, and the lifestyle/food environment; and the Internal Exposome, all exogenous or endogenous (bio)chemical entities measured in human biospecimens and influenced by the external urban exposome, including biomarkers of the exposures in the environment that are taken up, metabolised and might lead to biological changes.
EXPANSE will take the next step in Exposome research by introducing the following key elements into its research programme: bringing together large health datasets (millions of individuals) in support of sufficiently sized Exposome studies, addressing the evolution of both the exposome and health over the life-course, moving from observing static associations towards developing dynamic interventions, and introducing methodological innovations and practical tools. By establishing the largest European urban Exposome consortium to date and building upon the methodological development and insights gained from the first generation of exposome projects, EXPANSE will address the most pertinent questions for urban planners, policy makers and inhabitants in Europe.
B3283 - Early adulthood socioeconomic transitions and the development of inequalities in cardiovascular health - 15/04/2019
There is strong patterning of cardiovascular disease according to socio-economic position (SEP), typically based on education level, type of occupation or level of income. This research aims to assess the contribution of childhood and early adulthood SEP to inequalities in risk factors related to cardiovascular disease. To understand early adulthood SEP we will investigate the pathways that young adults take through different levels of education, different types of employment, and time not in education, employment or training during early adulthood (age 18-25), which will together contribute to their overall SEP over this period. We will look at the relationships between groups of the population experiencing different early adulthood SEP and risk factors for cardiovascular disease, such as being overweight, having high blood pressure or different levels of blood lipids.
B3282 - Genomic prediction of 25 hydroxyvitamin D using lasso regression - 02/04/2019
B3280 - Are dietary patterns in childhood associated with later alcohol use - 01/04/2019
Links have been made between increased sugar and fat consumption in childhood and regular alcohol consumption in adolesence. We plan to see whether this association is present in the ALSPAC cohort and to see whether dietary patterns in childhood (whereby the whole diet is summarised into a handful of scores based on underlying correlations between food groups) are associated with the use of alcohol at 17 years of age
B3281 - Request to include sexual orientation measures in upcoming ALSPAC data collection waves - 05/04/2019
The aim of this request is to ask the ALSPAC team to consider including the measurement of sexual orientation (sexual attractions and sexual experiences) in future data collection. Sexual orientation is an important feature of human nature and diversity. While most people identify as heterosexual (attracted to the opposite sex), a substantial number of the population identify as non-heterosexual. This includes lesbian, gay, and bisexual identification as well as a range of emerging sexualities (such as asexual). Scholars from across medicine, behavioural and social sciences have also found that nonheterosexual people are at greater risk of common mental health problems such as depression, anxiety, and suicide compared to heterosexual people. These problems tend to start early in adolescence among nonheterosexual people. It is important to understand the social, psychological, and biological factors that might be involved in contributing to this mental health disparity. This will help researchers to identify the most important risk factors and develop interventions (e.g., psychological interventions) to reduce the burden of these problems on nonheterosexual people. Studies using data from ALSPAC have already helped to identify some of these risk factors and thus continued measurement of sexual orientation in the cohort will prove invaluable to future researchers. In general, future basic and applied scientific research on sexual orientation will provide greater social and cultural understanding of the diversity in human sexuality.
B3278 - Understanding the multimorbidity of non-communicable diseases from childhood to adulthood MOCHA - 25/03/2019
Multimorbidity (i.e. the co-occurrence of more than one chronic disease in the same person) has been recognised as
a major public health problem in the old age. In contrast, knowledge of multimorbidity among children,
adolescents and young adults is lacking. MOCHA challenges the prevailing concept that multimorbidity is
mainly an issue of ageing. MOCHA hypothesises that multimorbidity originates early in life and continues to develop throughout the life
course.
B3279 - SpiroMeta - 25/03/2019
B2940 - Development of autoimmunity in the general population - 04/04/2019
Type 1 diabetes, coeliac disease, autoimmune gastritis and thyroiditis are examples of autoimmune conditions where the immune system mistakenly responds to, and attacks, healthy cells of the body. Individually autoimmune diseases are relatively rare, but together they affect at least 5% of the UK population. The immune response that causes these diseases includes the production of antibodies to cells of the pancreas, gut, and thyroid. These antibodies can be measured in the blood and can act as markers of disease before symptoms occur. The antibodies to cells of the pancreas are highly predictive for type 1 diabetes; when an individual has multiple markers they have a 50-70% risk of developing diabetes in the next decade. These markers can be detected in early life (from 6 months of age) but may arise later and often persist for many years before disease onset. Although markers of autoimmunity have been well studied in family members of individuals with autoimmunity, particularly in childhood, they are rarely studied in people without a family history of disease. Studying markers of pancreatic and co-existing autoimmunity in blood samples from ALSPAC children and parents will complement data from our family-based study and tell us whether some people develop these markers during childhood, adolescence or in later life. Is autoimmunity âexplosiveâ with rapid appearance of autoantibodies followed by clinical onset of symptoms or does it follow a more indolent pathway? This will help us understand why different individuals are diagnosed with autoimmune disease very early in life, while others are diagnosed as adults.